NASDAQ
Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis
Open
$6.17
Previous Close
$6.11
Day High
$6.40
Day Low
$6.13
52 Week High
$18.12
52 Week Low
$5.70
No price data available for this timeframe.